Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study
ESMO Open · 2026-05 · 11 (5) · 106901
DOI: 10.1016/j.esmoop.2026.106901 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Open, 2026-05. Verfasst von A Cigliola und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cig…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cigliola.antonio@hsr.it.
- Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
- Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
- The University of Texas MD Anderson Cancer Center, Houston, USA; City of Hope Comprehensive Cancer Center, Duarte, USA.
- Vita-Salute San Raffaele University, Milan, Italy; Department of Pathology, IRCCS San Raffaele Hospital, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy; Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy.
Zitieren
APA
Cigliola, A., Maiorano, B. A., Rossari, F., Tateo, V., Mercinelli, C., Dizman, N., Colecchia, M., De Cobelli, F., Larcher, A., Rosiello, G., Briganti, A., Montorsi, F., Capitanio, U., Spiess, P. E., Agarwal, N., Pal, S. K., & Necchi, A. (2026). Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study. ESMO Open, 11(5), 106901. https://doi.org/10.1016/j.esmoop.2026.106901
Vancouver
Cigliola A, Maiorano BA, Rossari F, Tateo V, Mercinelli C, Dizman N, et al. Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study. ESMO Open. 2026;11(5):106901. doi:10.1016/j.esmoop.2026.106901
BibTeX
@article{Cigliola2026,
author = {Cigliola, A and Maiorano, B A and Rossari, F and Tateo, V and Mercinelli, C and Dizman, N and Colecchia, M and De Cobelli, F and Larcher, A and Rosiello, G and Briganti, A and Montorsi, F and Capitanio, U and Spiess, P E and Agarwal, N and Pal, S K and Necchi, A},
title = {Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study},
journal = {ESMO Open},
year = {2026},
volume = {11},
number = {5},
pages = {106901},
doi = {10.1016/j.esmoop.2026.106901}
}
EUVIMED